Total Payments
$14,607
2021 Payments
$20.00
Companies
7
Transactions
76
Payment Breakdown by Category
Research$7,686 (52.6%)
Travel$5,118 (35.0%)
Food & Beverage$1,783 (12.2%)
Gifts$20.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7,686 | 29 | 52.6% |
| Travel and Lodging | $5,118 | 22 | 35.0% |
| Food and Beverage | $1,783 | 24 | 12.2% |
| Gift | $20.00 | 1 | 0.1% |
Payments by Type
Research
$7,686
29 transactions
General
$6,921
47 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $6,102 | 19 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $3,382 | 25 | $0 (2019) |
| PFIZER INC. | $2,441 | 10 | $0 (2021) |
| Regeneron Pharmaceuticals, Inc. | $1,659 | 11 | $0 (2017) |
| AbbVie, Inc. | $859.53 | 9 | $0 (2019) |
| Eli Lilly and Company | $150.00 | 1 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $13.17 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $20.00 | 1 | PFIZER INC. ($20.00) |
| 2020 | $163.17 | 2 | Eli Lilly and Company ($150.00) |
| 2019 | $4,087 | 28 | Merck Sharp & Dohme Corporation ($2,116) |
| 2018 | $2,351 | 22 | Merck Sharp & Dohme Corporation ($1,267) |
| 2017 | $7,986 | 23 | Allergan Inc. ($5,017) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/03/2021 | PFIZER INC. | — | Gift | In-kind items and services | $20.00 | General |
| 09/24/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Central Nervous System | ||||||
| 07/31/2020 | Eli Lilly and Company | — | — | In-kind items and services | $150.00 | Research |
| Study: ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE | ||||||
| 07/10/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $40.00 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 07/10/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $23.20 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 05/23/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Travel and Lodging | In-kind items and services | $78.41 | General |
| Category: VACCINE | ||||||
| 05/23/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: VACCINE | ||||||
| 05/23/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Food and Beverage | In-kind items and services | $49.98 | General |
| Category: VACCINE | ||||||
| 05/23/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: VACCINE | ||||||
| 05/22/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Travel and Lodging | In-kind items and services | $247.06 | General |
| Category: VACCINE | ||||||
| 05/22/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Travel and Lodging | In-kind items and services | $103.13 | General |
| Category: VACCINE | ||||||
| 05/22/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Food and Beverage | In-kind items and services | $81.19 | General |
| Category: VACCINE | ||||||
| 05/22/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: VACCINE | ||||||
| 05/22/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: VACCINE | ||||||
| 05/22/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Food and Beverage | Cash or cash equivalent | $5.68 | General |
| Category: VACCINE | ||||||
| 05/21/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Travel and Lodging | In-kind items and services | $1,025.03 | General |
| Category: VACCINE | ||||||
| 05/21/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Travel and Lodging | In-kind items and services | $247.06 | General |
| Category: VACCINE | ||||||
| 05/21/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Travel and Lodging | Cash or cash equivalent | $83.20 | General |
| Category: VACCINE | ||||||
| 05/21/2019 | Merck Sharp & Dohme Corporation | V114 (Biological) | Food and Beverage | Cash or cash equivalent | $40.00 | General |
| Category: VACCINE | ||||||
| 04/05/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $335.96 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 04/05/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $58.57 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 04/05/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $36.06 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 04/05/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $18.86 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 04/05/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $18.75 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 04/04/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $204.06 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE | Allergan Inc. | $3,216 | 3 |
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFECT OF PRALUENT ON NEUROCOGNITIVE FUNCTION IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA OR WITH NON-FAMILIAL HYPERCHOLESTEROLEMIA AT HIGH AND VERY HIGH CARDIOVASCULAR RISK | Regeneron Pharmaceuticals, Inc. | $1,659 | 11 |
| A PHASE 2, RANDOMIZED, MULTICENTER, DOUBLE-BLIND, VEHICLE-CONTROLLED STUDY TO EVALUATE SAFETY AND EFFICACY OF THREE DOSES OF ESTRADIOL VAGINAL CAPSULE IN POSTMENOPAUSAL WOMEN WITH VULVOVAGINAL ATROPHY | Allergan Inc. | $1,230 | 3 |
| M16-100 | AbbVie, Inc. | $859.53 | 9 |
| A MULTICENTER, RANDOMIZED, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLOERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRANE WITH R WITHOUT AURA | Allergan Inc. | $571.00 | 2 |
| ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE | Eli Lilly and Company | $150.00 | 1 |
About Dr. Mary Beth Manning, M.D
Dr. Mary Beth Manning, M.D is a Emergency Medicine healthcare provider based in Bedford, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1881670396.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Beth Manning, M.D has received a total of $14,607 in payments from pharmaceutical and medical device companies, with $20.00 received in 2021. These payments were reported across 76 transactions from 7 companies. The most common payment nature is "" ($7,686).
Ad
Practice Information
- Specialty Emergency Medicine
- Location Bedford, OH
- Active Since 12/16/2005
- Last Updated 06/11/2008
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1881670396
Products in Payments
- V114 (Biological) $2,116
- PRALUENT ALIROCUMAB INJECTION (Biological) $1,659
- TRUMENBA (Biological) $1,310
- V160 (Biological) $1,267
- ESTRACE CREAM (Drug) $1,230
- PREVNAR - 13 (Biological) $1,112
- Androgel (Drug) $859.53
- AUSTEDO (Drug) $13.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Bedford
Dr. Winston Yap, Md, MD
Emergency Medicine — Payments: $25,329
Emergency Medicine $25,329
Dr. Michael Martino, Md, MD
Emergency Medicine — Payments: $3,010
Emergency Medicine $3,010
Dr. Angela Straface, Md, MD
Emergency Medicine — Payments: $2,408
Emergency Medicine $2,408
Nikki Wilkins, Md, MD
Emergency Medicine — Payments: $1,321
Emergency Medicine $1,321
Michelle Beeson, Md, MD
Emergency Medicine — Payments: $904.12
Emergency Medicine $904.12
Bob Rowland, Md, MD
Emergency Medicine — Payments: $590.14
Emergency Medicine $590.14